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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S153potential confounders. Moreover, the two different methods both gave
consistent results suggesting a small effect where higher BMI is associated
with worse outcomes. However, whilst the difference in 12 month OHS is
statistically signiﬁcant, these patients still receive substantial beneﬁt from
surgery, regardless of their pre-operative BMI. The ﬁndings suggest BMI
should not present a barrier to access THR in terms of PROMs.
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FREQUENCY AND PREDICTORS OF PARTICIPATION RESTRICTION
FOLLOWING KNEE REPLACEMENT: THE MOST STUDY
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L. Frey-Law5, D. Felson 2. 1Boston Univ., Boston, MA, USA; 2Boston Univ.
Med. Ctr., Boston, MA, USA; 3Univ. of Alabama Birmingham, Birmingham,
AL, USA; 4Univ. of California, San Francisco, CA, USA; 5 The Univ. of Iowa,
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Purpose: While it is assumed that knee replacement surgery (KR) allows
a person to participate more fully in their desired daily activities, little
research has explored outcomes of participation in this population. While
w20% of adults > 65 years old report restrictions in activities outside the
home such as shopping or visiting, this is currently unknown among those
post-KR. Given the critical importance of participation to one's health and
the climbing rates of KR, we sought to explore the proportions of those
with restricted participation prior to and post-KR, and to determine
potential demographic and clinical factors that may be associated with
participation restrictions in this population.
Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded
longitudinal cohort study of 3,026 older persons with/at high risk of
developing knee osteoarthritis at the time of enrollment. The Late Life
Disability Instrument, Instrumental Limitation subscale (LLDI-IL), admin-
istered at each study visit (0, 30, and 60 months), was used to ascertain
participation. Participation restriction was deﬁned using a previously
established cut-point of < 67.6/100, with lower scores indicating more
restriction. Subjects with KR following enrollment and LLDI-IL data at least
1 year post-KR were included.
We determined the proportion of subjects with participation restrictions
overall and stratiﬁed by sex, race, and age at KR for the visit prior to KR and
 1 or  2 years post-KR. We analyzed differences between the propor-
tions prior to and 1 year using the McNemar test. We evaluated the odds
of having participation restrictions  1 year post-KR for the following
independent variables: demographic (sex, race, age at KR, educational
attainment), and clinical (depressive symptoms 16 on CES-D, quadriceps
strength, WOMAC pain severity in the KR or contralateral knee 10/20, #
of knees replaced, body mass index  30, pre-KR WOMAC physical func-
tion, and # of comorbidities) using logistic regression. Data on demo-
graphic and clinical factors were collected at the same clinic visit as the
LLDI-IL.
Results: Therewere 218 subjects with a KR between enrollment and the 60
month visit and who had LLDI-IL data  1 year post-KR, of which 160 also
had LLDI-IL data  2 years post-KR. They included 70% women, 87%
Whites; with a baseline mean age of 64.8 (SD 7.4) and mean BMI of 33.
There was a decline in the proportion with participation restrictions from
pre-KR to 1 year post-KR for all groups, reaching statistical signiﬁcance
among the youngest subjects, while the oldest experienced an increase in
the proportion with participation restriction (Table 1).
There were increased odds of participation restrictions for those with
higher depressive symptoms than those with lower (adj. OR 4.5 (2.0, 10.3)
and among those with at least moderate pain in the KR or contralateral
knee compared to those with no or less pain (adj. OR 7.0 (2.2, 22.7) and 5.3
(1.6, 16.9) respectively). There were non-signiﬁcant associations of Non-
White race and older age with participation restrictions (Table 2).
Conclusions: Although the proportions of persons with participation
restrictions decreased following KR among most demographic groups,
they continue to be much higher than the general population. While
factors such as sex, comorbidities, and strength were not associated with
participation restriction, high depressive symptoms and pain in either
knee appear to be important factors associated with this restriction. As the
rate of KR is continuing to rise dramatically, along with a growing recog-
nition that participation is an important KR patient outcome, there is
a need for further studies on risk factors for participation restrictions.Ă
Ă
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MORTALITY IN OSTEOARTHRITIS PATIENTS CONSULTING HEALTH CARE
R. Liu, W.Y. Kwok, T.P. Vliet Vlieland, H.M. Kroon, I. Meulenbelt,
F.R. Rosendaal, T.W. Huizinga, M. Kloppenburg. Leids Univ.ir Medisch
Centrum, Leiden, Netherlands
Purpose: Metabolic factors such as obesity play a role in the etiology of
osteoarthritis. A connection between osteoarthritis (OA), metabolical
syndrome and subsequently mortality has been suggested. Evidence
concerning mortality has unfortunately been controversial, we therefore
sought to examine the occurrence of mortality in our OA cohorts.
Methods: 384 patients were included in the ‘Genetics ARthrosis and
Progression’ (GARP) study, a prospective longitudinal cohort, with symp-
tomatic OA at multiple sites in the hand or in at least 2 of the following
sites: hand, knee, hip or spine. Patients consulted rheumatologists,
orthopedic surgeons or general practitioners and underwent baseline
assessment between August 2000 and March 2003.
For the replication analysis, we studied 460 patients who consulted the
rheumatology outpatient clinic and the clinical nurse specialist. They were
consecutively included in the ‘Zorgpad artrose’ cohort between August
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S1542005 and April 2009 and were diagnosed by the rheumatologist with
primary hand, knee or hip OA.
All subjects were followed until 2 November 2011.Mortality was compared
between included patients with OA and the general population in the
Netherlands, matched for both age and gender. For GARP, the expected
numbers of deaths came from age and gender speciﬁc mortality data
provided in the mortality statistics from 2006 in 5-year age bands and for
‘Zorgpad artrose’ the data came from 2009. Standardized Mortality Ratios
(SMR) with 95% conﬁdence intervals (95% CI) were calculated using STATA
(version 10.1).
Results: The GARP study consisted of 384 participants (82% women) and
the mean age at inclusion was 60.1 (range 42-79). The duration of follow-
up was 9.0 (SD 1.2). No excess mortality was observed in OA patients when
compared to the general population. 26 patients died, while the expected
number of deaths was 48 (SMR 0.54, 95% CI 0.37 - 0.79). The SMR was 0.47
(0.29 - 0.76) in women and 0.73 (0.39 - 1.35) in men. Healthy cohort effect
was also tested and not likely present.
In our replication cohort we found similar results (11 patients died, SMR
0.45, 95% CI 0.25 - 0.82). The SMR was also lower in women (0.40, 0.20 -
0.81) than in men (0.66, 0.21 - 2.06)
Conclusions: In patients consulting health care, OA does not lead to
a higher mortality rate in women and a similar trend can be observed
in men. These results do not support the hypothesis that metabolic
syndrome is an important cause of OA and would inﬂuence the
mortality of patients consulting primary or secondary health care for
their complaints. Whether this is due to selection of patients or
reﬂects a true absence of metabolic syndrome in OA has to be further
investigated.305
THE ASSOCIATION OF STATIN USE AND INCIDENT RADIOGRAPHIC KNEE
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Purpose: Statin medications are widely used and have been shown to
reduce inﬂammation in cardiovascular disease; animal data suggests
a protective role for statins in inﬂammation associated with cartilage and
bone. Based on these ﬁndings, we wanted to evaluate the association of
statin use with the risk of incident knee radiographic osteoarthritis
(ROA).
Methods: Subjects were enrolled in MOST, an NIH-funded cohort study of
3026 men and women ages 50-79 years with, or at high risk of knee OA.
Subjects had baseline and 30 month follow-up PA and lateral knee x-rays.
Tibiofemoral (TF) ROA was deﬁned as the presence of Kellgren/Lawrence
(K/L) grade  2. Whole knee (WK) ROA was deﬁned as the presence of
either TFROA or patellofemoral (PF) OA, deﬁned as either (1) PF osteophyte
grade  2, or 2) as a PF osteophyte grade  1 plus one or more of PF joint
space narrowing, sclerosis or cysts . Incident cases were knees without
TFROA (or WKROA) at baseline that developed it at 30 months. Statin useAssociation of Statin Use and Incident TFROA
OVERALL WOMEN
No use Continuous use No use
Subjects 1243 432 764
Knees 1962 655 1208
Events 153 (7.3%) 60 (8.4%) 100 (7.7
Unadjusted model ref 1.18 (0.85-1.63) 0.32 ref
Adjusted Model 1.13 (0.80-1.59) 0.49was determined by a review of current (past 30 days) prescription medi-
cations, brought to the clinic by participants, at the baseline and 30 month
visits. We used logistic regression in a knee based analysis, with GEE to
account for within-person correlation, to determine the association of
statin use at both the baseline and 30 month visit (“continuous use”)
compared to no statin use at either the baseline or 30 month visit (“no
use”) with outcomes of incident TFROA and incident WKROA. Analyses
were adjusted for age, race, clinic site, BMI and self-reported cardiovas-
cular disease.
Results: 2,830 knees from 1,675 subjects were eligible for incident TFROA
in subjects who had either “no use” (1,243 subjects) or “continuous use”
(432 subjects) of statins over the 30 month period. There were no signif-
icant differences in baseline characteristics of the two statin use groups
except for BMI [“no use”¼ 29.3  5.3; “continuous use”¼30.4  5.1; p-
value¼ 0.0006]. In men and women combined, there was no signiﬁcant
association between statin use and incident TFROA in the unadjusted
model (OR¼1.18 (0.85-1.63)), or after adjusting for covariates (OR¼ 1.13
(0.80-1.59)). Stratifying by gender suggested a different direction of asso-
ciation of statin use and TFROA in women compared to men [women:
adjusted OR¼ 1.37 (0.88-2.15); p-value¼ 0.17; men: adjusted OR¼ 0.84
(0.51-1.41); p-value¼ 0.52); p-value for interaction by gender ¼ 0.096]. All
results, including stratiﬁed by gender, were similar for the outcome of
incident WKROA.
Conclusions:We found no signiﬁcant protective effect of statin use on the
risk of incident knee ROA at 30 months, and can exclude a greater than 20%
reduction in the odds of TFROA with 95% conﬁdence. Because this is an
observational study, residual confounding by indication may in part
explain these results.306
STAGED MEDIAL OPENING WEDGE HIGH TIBIAL OSTEOTOMY FOR
BILATERAL VARUS GONARTHROSIS
E. Sischek 1,2, T. Birmingham 1,2, I. Jones 1,2, R. Martin 3, J.R. Gifﬁn 1,3. 1 The
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Purpose: Medial opening wedge high tibial osteotomy (HTO) aims to
improve pain and function by correcting varus alignment and lessening
aberrant loads on the medial compartment of the tibiofemoral joint.
Because varus gonarthrosis often affects both knees, staged bilateral HTO
may be an appropriate treatment approach for such patients. However, we
are unaware of any previous studies evaluating outcomes after these
staged procedures. Objectives of the present study were: 1) To evaluate
changes in radiographic alignment, dynamic knee joint loading, patient-
reported and performance-based outcomes after staged bilateral medial
opening wedge HTO, and 2) To compare outcomes in patients having the
second surgery staged either within or beyond 12 months of the ﬁrst
surgery.
Methods: Using a prospective case series design (level of evidence 4), 37
patients with bilateral varus alignment (-8.36  2.98) and medial
compartment osteoarthritis (OA) underwent staged bilateral medial
opening wedge HTO. Patients underwent full-limb standing ante-
roposterior radiographs to determine frontal plane alignment (mechanical
axis angle) and 3-dimensional gait analysis to estimate knee joint loadsMEN
Continuous use No use Continuous use
196 479 236
287 754 368
%) 37 (11.4%) 53 (6.6%) 23(5.9%)
1.57 (1.02-2.40) 0.04 ref 1.57(1.02-2.40) 0.04
1.37 (0.88-2.15) 0.16 0.84 (0.51-1.41) 0.52
